Medical Countermeasures Are Common Cold Coronaviruses a Hidden Variable in COVID-19 Vaccine Effectiveness?Global Biodefense StaffJuly 17, 2025
Medical Countermeasures Mpox Antiviral Clinical Trial Advances as WHO Extends Global EmergencyGlobal Biodefense StaffJuly 17, 2025
Medical Countermeasures Peptide-Based Monkeypox Vaccine Candidate Designed Using Viral Glycoprotein TargetGlobal Biodefense StaffJuly 14, 2025
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024 …
Study Shows Potential Benefits of Newer, Non-Egg-Based Flu Vaccines Medical Countermeasures January 31, 2024 …
DARPA Announces EQUIP-A-Pharma Program to Advance Agile Pharmaceutical Manufacturing Medical Countermeasures January 28, 2024 …
NIAID Funding Development of Biomarkers and Tools for Radiation Emergency Triage Medical Countermeasures January 25, 2024 …
Promising New ‘circRNA’ Vaccines Explored in CEPI-HMRI Collaboration Medical Countermeasures January 25, 2024 …
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy Medical Countermeasures January 23, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery Medical Countermeasures November 11, 2023 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Contracts + Grants September 17, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …